US EditionPublished • loading... • Updated
Reversible Clozapine-Induced Antiphospholipid Syndrome
Summary by psychiatrist.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Reversible Clozapine-Induced Antiphospholipid Syndrome
Reversible Clozapine-Induced Antiphospholipid Syndrome Clozapine has been linked to venous thrombotic events (VTEs), as a dose-independent collateral effect, with a 3-to 27.5-fold increased risk compared to the general population.1–5 The risk is particularly higher during the first 3 months of treatment.6 Several pathophysiological mechanisms, not mutually exclusive, have been proposed for antipsychotic-associated VTE, such as drug-induced sedat…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
